Repligen
RGEN • NASDAQ • Stock Fundamentals
Repligen is a medical - instruments & supplies company in the healthcare sector trading on NASDAQ, led by CEO Olivier Loeillot, with a market cap of $7.5B.
Market Cap$7.5B
Employees1.8K
CEOOlivier Loeillot
CountryUnited States of America
Healthcare
Medical - Instruments & Supplies
Most Recent EarningsMay 5, 2026 · 1 month 8 days agoQ1 2026
View reportNext EarningsAug 4, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Repligen FAQ
Common questions about Repligen
Repligen (RGEN) has a market capitalization of $7.5B and trades on NASDAQ.
Repligen has approximately 1,783 employees.